About
Small molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalNorth & South Carolina
Clinical Trials (14)
View allTotal Trials
14
As Lead Sponsor
13
As Collaborator
1
Total Enrollment
2,693
By Phase
PHASE3: 3PHASE2: 7PHASE1/PHASE2: 2PHASE1: 2
By Status
COMPLETED: 8TERMINATED: 4RECRUITING: 1WITHDRAWN: 1
Clinical Trials Pipeline14 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06334133Lead Sponsor
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
PHASE3Recruiting
150 participants
Started: Jun 14, 2024 · Completed: Oct 31, 2026
NCT03980730Lead Sponsor
Study of Azeliragon in Patients With Mild Alzheimer's Disease and Impaired Glucose Tolerance
PHASE2Terminated
43 participants
Started: Jun 27, 2019 · Completed: Jan 29, 2021
NCT03335371Lead Sponsor
Evaluation of TTP399 in Patients With Type 1 Diabetes
PHASE1/PHASE2Completed
115 participants
Started: Oct 25, 2017 · Completed: Jan 6, 2020
NCT02916056Lead Sponsor
2-Year Extension Study of Azeliragon in Subjects With Alzheimer's Disease (STEADFAST Extension)
PHASE3Terminated
297 participants
Started: Dec 31, 2016 · Completed: Jun 1, 2018
NCT02653599Lead Sponsor
A Study to Evaluate Safety and Efficacy of TTP273 for 12 Weeks in Subjects With Type 2 Diabetes
PHASE2Completed
174 participants
Started: Dec 31, 2015 · Completed: Jan 31, 2017
Funding History (1)
D
Oct 5, 2015
Locations (1)
Headquarters
High Point, NC, United States
Map
Loading map...